Come up with a name for your new list and we'll add to it:
Nimbus Therapeutics raised a round of funding on June 27, 2013. Investors include
Monsanto Growth Ventures.
Nimbus Therapeutics, formerly Nimbus Discovery, harnesses the power of computational chemistry to design breakthroughs for the treatment of substantial and underserved human diseases. The company's fo…